Is biosimilarscanada.ca Safe? Security Analysis for Biosimilars Canada
https://biosimilarscanada.caCheck if biosimilarscanada.ca is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for biosimilarscanada.ca
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Biosimilars Canada is a national industry association dedicated to representing and advocating for the biosimilar medicines sector in Canada. The organization focuses on educating stakeholders including patients, healthcare providers, employers, and policymakers about the safety, efficacy, and benefits of biosimilars. Their market position is that of a trusted national voice promoting biosimilar adoption and policy support. The website reflects a professional and consistent brand image with clear navigation and relevant content tailored to their target audience. Technically, the website is built on WordPress using Elementor and JupiterX theme, leveraging modern SEO and performance optimization plugins such as Yoast SEO and WP Rocket. The site is mobile optimized and uses Google Analytics and Tag Manager for tracking. Hosting and domain registration are stable and appropriate for the organization's profile. From a security perspective, the site uses HTTPS with a good SSL configuration and domain status protections. However, DNSSEC is not enabled, and no explicit security or incident response policies are published on the site. Cookie consent mechanisms are absent despite the use of tracking scripts, indicating a gap in privacy compliance. No critical vulnerabilities or suspicious indicators were found. Overall, the website presents a low-risk profile with good business credibility and technical implementation. Strategic improvements in privacy compliance and security headers would enhance the security posture and trustworthiness further.
Detected Technologies
12 urgent findings need attention
1 critical · 11 high
- + 4 more findings in the full report below
Keep biosimilarscanada.ca under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
8 findings
15/100
GDPR Compliance
4 findings
53/100
NIS2 Compliance
8 findings
17/100
Email Security
3 findings
85/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Biosimilars Canada operates as an important healthcare industry association in Canada, focusing on biosimilar medicines. Their business model centers on advocacy, education, and stakeholder engagement rather than commercial sales. They target healthcare stakeholders, patients, employers, and policymakers, aiming to influence biosimilar adoption and reimbursement policies. The organization maintains partnerships with related industry groups such as Canadian Generics and IGBA Medicines. The website content and structure support their mission with educational resources, news updates, and campaign information. Growth indicators include recent news releases and active social media channels. The association is relatively small but well-established since 2015, with a clear national focus.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate security maturity level with HTTPS enforced and domain status protections that prevent unauthorized domain changes. The absence of DNSSEC is a minor security gap that could be addressed to improve domain integrity. No security headers were detected, and there is no published security policy or incident response information, which limits transparency and preparedness indicators. The use of third-party tracking scripts without a cookie consent mechanism suggests incomplete privacy compliance. No exposed sensitive data or vulnerable libraries were identified. Overall, the security posture is adequate for an informational website but could benefit from enhanced security controls and privacy practices.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to strengthen DNS security and prevent spoofing.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Biosimilars Canada
Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. They provide leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines, and advocate for policies supporting timely approval, reimbursement, market acceptance, and expanded use.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Domain status includes clientDeleteProhibited, clientTransferProhibited, clientUpdateProhibited
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is professionally designed and well-structured.
Get this report delivered to your inbox
Receive a summary of the biosimilarscanada.ca security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete biosimilarscanada.ca security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 79 days
Mixed Content Detected
MEDIUM2 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Registration Details
- •Privacy/proxy registration detected
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
High-Risk Service Exposed: FTP
HIGHPort 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer
Critical Service Exposed: MySQL
CRITICALPort 3306 (MySQL) is publicly accessible - MySQL - Database server
How does biosimilarscanada.ca compare?
See how biosimilarscanada.ca stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the biosimilarscanada.ca report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the biosimilarscanada.ca report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about biosimilarscanada.ca
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published